An observational study in Inactivity, Physical, Aging and Healthy Aging, sponsored by University of Toronto. Completed at 1 site in Canada. Open to participants aged 8 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by University of Toronto · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 73 studies in Sedentary Behavior with a site in Canada — 18 open to participants now, 19 under way, none of them phase 3. Sedentary Behavior · Canada.
Among the 73 studies in Sedentary Behavior with a site in Canada, this one is one of 5 that started in 2024, is one of 4 observational ones, and was the 67th registered.
1,276 studies on the registry are indexed under Sedentary Behavior; 292 are open to participants now.
Browse Sedentary Behavior studies →18 of the 73 studies in Sedentary Behavior with a site in Canada are open now. Recruiting first, the newest first:
University of British Columbia · Sites in Canada
Ages 50+
University of Alberta · Sites in Canada
Ages 50+
The Royal Ottawa Mental Health Centre · Sites in Canada
Ages 18–75
Nova Scotia Health Authority · Sites in Canada
Ages 65+
Université de Sherbrooke · Sites in Canada
Ages 18–65 · Healthy volunteers
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 184 Sedentary Behavior studies recruiting now, 77 (42%) set no upper age limit and 82 (45%) stop at 75 or younger; 30 take children under 18; 97 take healthy volunteers.
This study: 8 Years to 80 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
73 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 72 is below the median of 163 across 177 observational studies indexed under Sedentary Behavior.
Median enrollment 50 across the 69 interventional studies, 336 across the 4 observational. Of the 46 that completed or were terminated, 4 (9%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 73 has an industry lead sponsor. The 10 most frequent:
University of Toronto is the lead sponsor of 405 studies on the registry; 51 are open to participants now.
University of Toronto has 9 studies filed under Sedentary Behavior — fewer than ten, so there is no comparison to draw.
5 of the studies in Sedentary Behavior with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07396857Université de SherbrookeThe Role of EDHFs on Blood Pressure Following a Bout of Prolonged Sitting | 2026-12-15 |
| NCT06773949The Royal Ottawa Mental Health CentreFeasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression | 2027-01-31 |
| NCT06252259University of British ColumbiaEvaluating Implementation and Impact of the Adapted Choose to Move (CTM) Program | 2027-03 |
| NCT06446414University of British ColumbiaEvaluating Implementation and Impact of Provincial Scale-up of the Adapted Choose to Move (CTM) Program | 2027-04 |
| NCT06345937University of TorontoMultiple Risk Factor Intervention Trial (Ms. FIT) | 2027-08-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 73 studies in Sedentary Behavior with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan, between biological sexes, and with varying physical activity levels.
Skeletal muscle is a dynamic tissue that responds to anabolic (i.e., growth) stimuli such as protein ingestion and exercise. Differences in age and physical activity levels will influence an individual's ability to respond to these anabolic stimuli; this concept is known as anabolic sensitivity. For instance, older and less physically active individuals will display lower anabolic sensitivity (i.e., anabolic resistance) to a bout of exercise or the consumption of protein in comparison to younger, more physically active individuals. Seeing that individuals with anabolic resistance are at a greater risk for losing muscle mass over time, it is important to understand the anabolic sensitivity/resistance of an individual to assess for the efficiency of growth across the health and lifespan, in addition to a potential screen for metabolic alterations that could manifest into changes in lean body and muscle mass.
Traditional methods to assess for skeletal muscle anabolism and protein metabolism requires in-person and invasive research methods (i.e., stable isotope infusions and muscle biopsies) in controlled laboratory or clinical settings. However, there are many risks associated with these invasive procedures and they are not always feasible in all populations (e.g., children, clinical populations, etc..). Our lab has recently developed a non-invasive 13C breath test which employs an oral stable isotope tracer. Our breath test allows us to assess for anabolic sensitivity in response to protein ingestion, by determining how much of the ingested protein was used to build (synthesize) new proteins in our body (i.e., anabolism) or used as a source of energy (through a process called oxidation). As such, the purpose of the present study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan and with varying physical activity levels.
Convenience sample of individuals who qualify for the corresponding cohorts based on inclusion/exclusion criteria stated.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Children as defined by maturity offset via age from peak height velocity (aPHV \< -1.0 years).
Adolescents as defined by maturity offset via age from peak height velocity (aPHV -0.5 to +1.5 years)
Young adults as defined by chronological age between ages 18 - 35 years
Older adults as defined by chronological age between ages 60 - 80 years
Amino acid oxidation and net protein balance
Amino acid oxidation and net protein balance assessed by oral 1-13C Leucine tracer. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 6h post-prandial measurement period.
Time frame: 6 Hours
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Dec 2024 to primary completion in Dec 2025, 12 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion May 2025 → Dec 2025 and completion Aug 2025 → Dec 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.